申请人:Daiichi Pharmaceutical Co., Ltd.
公开号:US05587386A1
公开(公告)日:1996-12-24
N.sub.1 -(1,2-cis-2-halogenocyclopropyl)-substituted pyridonecarboxylic acid derivatives represented by the following formula (I) the terms of which are defined in the specification and the salts thereof are disclosed: ##STR1## These compounds have patent antibacterial activities against a wide variety of infectious bacteria and are useful as antibacterial agents by oral or parenteral administration.
以下是中文翻译:N.sub.1 -(1,2-顺式-2-卤代环丙基)-取代吡啶酮羧酸衍生物,其化学式如下(I),其中术语在说明书中有定义,以及其盐已被披露:这些化合物具有专利抗菌活性,可用作口服或静脉注射的抗菌剂,对多种感染性细菌具有抗菌活性。